# 115-hr-4482: Opioid Abuse Deterrence, Research, and Recovery Act of 2017

115-hr-4482, Opioid Abuse Deterrence, Research, and Recovery Act of 2017, is a 115th Congress bill sponsored by Rep. Meadows, Mark [R-NC-11] (R-NC); status Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. (as of 2025-11-18).

- Canonical: https://policyrisk.com/legislation/115-hr-4482
- As of: 2025-11-18
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 115-hr-4482
- Congress: 115
- Title: Opioid Abuse Deterrence, Research, and Recovery Act of 2017
- Status: Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
- Introduced: 2017-11-29
- Sponsor: Rep. Meadows, Mark [R-NC-11] (R-NC)
- Cosponsors: 2
- Policy area: Crime and Law Enforcement
- Touches household money: no
- Last recorded action: 2025-11-18

## Summary

Opioid Abuse Deterrence, Research, and Recovery Act of 2017 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II or III unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law. Certain opioid prescriptions are not subject to the limit (e.g., an opioid that is approved and prescribed for the treatment of an opioid use disorder). The Food and Drug Administration (FDA) must continue to work with stakeholders to promote the development of abuse-deterrent opioid formulations. The bill requires: (1) the Government Accountability Office to study and report on health care policy changes that may have contributed to the increase in opioid overdoses and deaths, and (2) the FDA to study the feasibility of replacing opioid prescribing limits established by this bill with evidence-based clinical guidelines for opioid prescribing.

## Cosponsors (2)

- Rep. Renacci, James B. [R-OH-16] (R-OH), 2017-11-29T00:00:00.000Z
- Sen. Budd, Ted [R-NC] (R-NC), 2018-01-11T00:00:00.000Z

## Related bills

- 115-hr-5499: Stephen Michael Gleason Congressional Gold Medal Act
- 115-hr-4274: Higher Education Reform and Opportunity Act of 2017
- 115-hr-4229: Protecting HOME Access Act of 2017
- 115-hr-4107: USS Indianapolis Congressional Gold Medal Act
- 115-hr-4099: To amend title 38, United States Code, to ensure that children of homeless veterans are included in the calculation of the amounts of certain per diem grants.
- 115-hr-3976: Access to Marketplace Insurance Act

## Sources
- [115-hr-4482 on Congress.gov](https://www.congress.gov/bill/115th-congress/house-bill/4482)

## Related
- [115-hr-5499: Stephen Michael Gleason Congressional Gold Medal Act](https://policyrisk.com/legislation/115-hr-5499)
- [115-hr-4274: Higher Education Reform and Opportunity Act of 2017](https://policyrisk.com/legislation/115-hr-4274)
- [115-hr-4229: Protecting HOME Access Act of 2017](https://policyrisk.com/legislation/115-hr-4229)
- [115-hr-4107: USS Indianapolis Congressional Gold Medal Act](https://policyrisk.com/legislation/115-hr-4107)
- [115-hr-4099: To amend title 38, United States Code, to ensure that children of homeless vete…](https://policyrisk.com/legislation/115-hr-4099)
- [115-hr-3976: Access to Marketplace Insurance Act](https://policyrisk.com/legislation/115-hr-3976)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/115-hr-4482 (as of 2025-11-18).